ALERT: Counterfeit Green Lumber Products Contain Undeclared Prescription Drug
Published: August 29, 2025 (FDA) Summary On August 29, 2025, the U.S. Food and Drug Administration published a safety alert based on findings by…
Read more →EMA backs first low-carbon propellant for a licensed inhaler: what’s changing with Trixeo/Riltrava Aerosphere, and why it matters
The headline On July 25, 2025, the European Medicines Agency (EMA) announced that it recommended a change in the propellant for two pressurised metered-dose…
Read more →EMA CHMP Spotlight: July 21–24, 2025 Meeting Highlights
1. New Medicines Recommended for Approval The EMA’s Committee for Medicinal Products for Human Use (CHMP) reviewed promising therapies and issued positive opinions for…
Read more →B. Braun Voluntary Nationwide Recall: What You Need to Know
Recall Overview Clinical Background & Trial Context While the recall centers on manufacturing quality, here’s what clinical data tells us about these fluids: Overview…
Read more →FDA Issues Class I Recall for Boston Scientific Carotid Stent
What Happened: Scope & Rationale On August 22, 2025, the FDA classified as Class I the recall of Boston Scientific’s Carotid WALLSTENT Monorail Endoprosthesis,…
Read more →FDA Issues Import Alerts on Olympus Medical Devices Made in Japan
Background & Regulatory Action On June 24, 2025, the U.S. Food and Drug Administration (FDA) issued Import Alert 89-04, targeting certain Olympus medical devices…
Read more →